0
Adding erythropoietin to cooling therapy for term newborns with birth asphyxia has no benefit over cooling therapy alone, a new study shows. The findings contrast with results from small trials in which erythropoietin appeared safe and effective.
Adding erythropoietin to cooling therapy for term newborns with birth asphyxia has no benefit over cooling therapy alone, a new study shows. The findings contrast with results from small trials in which erythropoietin appeared safe and effective.